Valuation (59%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | -77.58 | 30.38 |
| PEG Ratio (TTM) | -1.76 | 6.42 |
| P/S Ratio (TTM) | 0.90 | 6.46 |
| P/B Ratio (TTM) | 2.01 | 18.16 |
| P/FCF Ratio (TTM) | 23.03 | 27.88 |
| Price to 5YR AVG Earnings Ratio | 24.11 | 35.72 |
| Price to 5YR AVG FCF Ratio | 13.07 | 35.45 |
Profitability (5%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | -2.02% | 9.70% |
| ROE (TTM) | -2.69% | 66.70% |
| Net Profit Margin (TTM) | -1.16% | 21.06% |
| ROIC 5YR AVG | 8.63% | 61.25% |
Growth (53%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | -816.41% | 24.90% | -27.31% |
| Revenue | 2.13% | 7.97% | 3.21% |
| Net Income | -821.26% | 26.33% | -26.33% |
| Cash Flow | 138.32% | 1,157.14% | 727.99% |
Health (77%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 2.98 | 2.92 |
| Quick Ratio (TTM) | 2.98 | 2.92 |
| D/E Ratio (TTM) | 0.01 | 1.28 |
| Interest Coverage (TTM) | 6.51 | 25.18 |
| Piotroski F-Score | 3 | 8 |
| Altman Z-Score | 7.03 | 4.40 |
| LTL to 5YR AVG FCF | 0.29 | 3.75 |
| Shares Outstanding Growth 5YR AVG | 1.19% | -0.65% |